MedMira Continues Momentum in Eastern Europe Expanding Distribution Network to Include Moldova and Ukraine

Regional Distributor Enters New Markets with MiraCare and Multiplo Tests

29-Apr-2008

MedMira Inc. announced that it continues to build sales momentum, expand into new sales territories, and extend its product reach in Eastern Europe. Building on an initial distribution channel in Romania MedMira is expanding its footprint in the region to include the Republic of Moldova and Ukraine. Together with its regional distribution partner, S.C. Roned International S.R.L., MedMira will bring MiraCare(TM) Rapid HIV Test to these markets immediately and begin the approval process for Multiplo(TM) Rapid HBV/HIV/HCV Test.

"We're very excited about bringing MedMira's products to our customers in Moldova and Ukraine following the positive response we have had in Romania. MedMira's unique Multiplo line of tests has captured the interest of many levels of government in all three countries. In Romania, hepatitis/HIV co-infections are very serious and we are seeking our government's full cooperation in approving MedMira's Multiplo triple test at the earliest possible date," said Dumitru Vescu, Executive Director of S.C. Roned International S.R.L. and President of the Romania-Moldova Chamber of Commerce. "We have started the process to allow MedMira's Multiplo test to be distributed through the Over-the-Counter (OTC) channels in Romania and we are also working with local NGO tenders to further expand the sales opportunities."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

DURAN Group launches anniversary campaign to celebrate 120 years of laboratory glassware

DURAN Group launches anniversary campaign to celebrate 120 years of laboratory glassware

MedMira Extends Market Reach into Southeast Asia with Contract for One Million HIV Tests - SE Asia Latest Target Market in Growing Global Distributor Network

SAFC and Novozymes Biopharma extend joint agreement for the exclusive distribution of LONGR3 growth factor

ARIUS Research Signs Anti-Cancer Antibody Discovery Deal with Takeda - Three-Year Collaboration to look for Novel Cancer Treatments

Amorfix announces Michael Sonnenreich as new director and establishment of a scientific advisory board

ALTANA AG: Sale of pharmaceuticals business to Nycomed - Purchase price of approx. EUR4.5 billion

MediGene and The Johns Hopkins University Sign Development Collaboration for First Vaccine Candidates from MediGene's AAVLP Platform - Examination of product candidates for the prevention of HPV-associated diseases

Lexicon Genetics Initiates Clinical Trials of LX1031 for Irritable Bowel Syndrome

AMRI promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

Market Opportunities Abound for Life Science Suppliers in Multi-Billion Dollar U.S. Market for Biodefense Research

MIT biologists find that restoring the gene for cancer protein p53 slows spread of advanced tumors

Enzo Biochem Granted European Patent For Displacer Technology To Treat Gene Abnormalities - Methodology Could Make Possible Modification or Corrections of Cell Mutations